155 related articles for article (PubMed ID: 34967360)
21. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
[TBL] [Abstract][Full Text] [Related]
22. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
[TBL] [Abstract][Full Text] [Related]
23. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
[TBL] [Abstract][Full Text] [Related]
25. Steroids and macular edema from retinal vein occlusion.
Glacet-Bernard A; Coscas G; Zourdani A; Soubrane G; Souied EH
Eur J Ophthalmol; 2011; 21 Suppl 6():S37-44. PubMed ID: 23264327
[TBL] [Abstract][Full Text] [Related]
26. SCORE2 Report 2: Study Design and Baseline Characteristics.
Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; Figueroa M; Dugel PU;
Ophthalmology; 2017 Feb; 124(2):245-256. PubMed ID: 27863843
[TBL] [Abstract][Full Text] [Related]
27. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
Papadia M; Misteli M; Jeannin B; Herbort CP
Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
[TBL] [Abstract][Full Text] [Related]
28. The laser combined with intravitreal injection of ranibizumab for treatment of macular edema secondary to branch retinal vein occlusion: A protocol for systematic review and meta-analysis.
Chen G; Chen P; Chen X; Wang J; Peng X
Medicine (Baltimore); 2021 Jan; 100(4):e23675. PubMed ID: 33530168
[TBL] [Abstract][Full Text] [Related]
29. Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA; Scott IU; VanVeldhuisen PC; King J; Ip MS; Blodi BA; Oden NL;
JAMA Ophthalmol; 2021 Dec; 139(12):1285-1291. PubMed ID: 34709363
[TBL] [Abstract][Full Text] [Related]
30. Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes.
Ciulla T; Pollack JS; Williams DF
Br J Ophthalmol; 2021 Dec; 105(12):1696-1704. PubMed ID: 33055088
[TBL] [Abstract][Full Text] [Related]
31. Treatments for macular oedema following central retinal vein occlusion: systematic review.
Ford JA; Clar C; Lois N; Barton S; Thomas S; Court R; Shyangdan D; Waugh N
BMJ Open; 2014 Feb; 4(2):e004120. PubMed ID: 24513867
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Follow-Up Changes of Central Choroidal Thickness Thinning after Repeated Anti-VEGF Therapy Injections in Patients with Central Retinal Vein Occlusion-Related Macular Edema with Systemic Hypertension.
Kida T; Osuka S; Fukumoto M; Sato T; Harino S; Oku H; Ikeda T
Ophthalmologica; 2020; 243(2):102-109. PubMed ID: 31851998
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of intravitreal pharmacotherapy for macular edema secondary to retinal vein occlusion: A protocol for the systematic review and network meta-analysis.
Zhang Y; Duan J; Chang T; Li X; Wang M; Zhang M
Medicine (Baltimore); 2020 Sep; 99(38):e22267. PubMed ID: 32957378
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the One-Year Efficacy of Combined Anti-VEGF and Dexamethasone Implant Treatment for Macular Edema in Retinal Vein Occlusions.
Ren F; Gong H; Zhang H; Zhang X; Liu X; Li J; Zhang G
Med Sci Monit; 2023 Jun; 29():e939277. PubMed ID: 37301978
[TBL] [Abstract][Full Text] [Related]
35. Current Outcomes of Anti-VEGF Therapy in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusions: A Systematic Review and Meta-Analysis.
Spooner K; Hong T; Fraser-Bell S; Chang A
Asia Pac J Ophthalmol (Phila); 2019; 8(3):236-246. PubMed ID: 31132002
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.
Campochiaro PA; Bhisitkul RB; Shapiro H; Rubio RG
Ophthalmology; 2013 Apr; 120(4):795-802. PubMed ID: 23260261
[TBL] [Abstract][Full Text] [Related]
37. Combination intravitreal anti-vascular endothelial growth factor inhibitors and macular laser photocoagulation relative to intravitreal injection monotherapy in macular oedema secondary to retinal vein occlusion: a meta-analysis of randomized controlled trials.
Bhambra N; Sayal AP; Popovic MM; Muni RH; Kertes PJ
Eye (Lond); 2022 Dec; 36(12):2271-2278. PubMed ID: 34819660
[TBL] [Abstract][Full Text] [Related]
38. Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis.
Ji K; Zhang Q; Tian M; Xing Y
Medicine (Baltimore); 2019 May; 98(22):e15798. PubMed ID: 31145307
[TBL] [Abstract][Full Text] [Related]
39. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; King J; Antoszyk AN; Peters MA; Tolentino M;
JAMA Ophthalmol; 2017 Jun; 135(6):639-649. PubMed ID: 28492860
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy and safety of traditional Chinese patent medicine for anxiety disorders in children or adolescence: A protocol for systematic review and network meta-analysis.
Jiang Z; Wang J; Yu X; Li C; Shao Y; Wang Z
Medicine (Baltimore); 2020 Sep; 99(39):e22274. PubMed ID: 32991427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
